Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.
about
Direct dynamin-actin interactions regulate the actin cytoskeleton.PodocytesCharcot-Marie-Tooth disease and intracellular trafficCell biology and pathology of podocytesPodocyte endocytosis in the regulation of the glomerular filtration barrierThe function of endocytosis in podocytesNovel siRNA delivery system to target podocytes in vivoEstablishment of protein delivery systems targeting podocytesDisruption of Myosin 1e promotes podocyte injuryCD2AP in mouse and human podocytes controls a proteolytic program that regulates cytoskeletal structure and cellular survivalDysregulated nephrin in diabetic nephropathy of type 2 diabetes: a cross sectional studyRegulation of dynamin oligomerization in cells: the role of dynamin-actin interactions and its GTPase activity.Structure of the kidney slit diaphragm adapter protein CD2-associated protein as determined with electron microscopy.Podocyte biology and pathogenesis of kidney diseaseRole of dynamin, synaptojanin, and endophilin in podocyte foot processes.Adapting mass spectrometry-based platforms for clinical proteomics applications: The capillary electrophoresis coupled mass spectrometry paradigm.Sources of Urinary Proteins and their Analysis by Urinary Proteomics for the Detection of Biomarkers of DiseaseSystematic analysis of a novel human renal glomerulus-enriched gene expression dataset.Roles for cathepsins S, L, and B in insulitis and diabetes in the NOD mouse.Cathepsin L inhibition suppresses drug resistance in vitro and in vivo: a putative mechanism.Podocyte injury induces nuclear translocation of WTIP via microtubule-dependent transport.Reduction of proteinuria through podocyte alkalinization.Toward the development of podocyte-specific drugs.The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.Proteinuria: an enzymatic disease of the podocyte?Enzymatic disease of the podocyte.The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury.APOL1 risk variants enhance podocyte necrosis through compromising lysosomal membrane permeability.TRPC6 channels and their binding partners in podocytes: role in glomerular filtration and pathophysiology.Proteases in cardiometabolic diseases: Pathophysiology, molecular mechanisms and clinical applications1,25-dihydroxyvitamin D(3) inhibits podocyte uPAR expression and reduces proteinuriaMyo1e impairment results in actin reorganization, podocyte dysfunction, and proteinuria in zebrafish and cultured podocytesCathepsin K-mediated Notch1 activation contributes to neovascularization in response to hypoxia.Pharmacological targeting of actin-dependent dynamin oligomerization ameliorates chronic kidney disease in diverse animal models.Proteinuria: is it all in the foot?One Year of Enzyme Replacement Therapy Reduces Globotriaosylceramide Inclusions in Podocytes in Male Adult Patients with Fabry Disease.Emerging role of autophagy in kidney function, diseases and agingAlteration of histone H3K4 methylation in glomerular podocytes associated with proteinuria in patients with membranous nephropathy.Dynamin-mediated Nephrin phosphorylation regulates glucose-stimulated insulin release in pancreatic beta cells.Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney.
P2860
Q24302210-CC4475B5-F5E9-4DE7-B9C4-4518DB771709Q26766118-CBBE931D-B993-4995-89EC-A60E369D31DBQ26824841-16CDDFFC-A644-454F-BFDD-5A7ED4891CE6Q26853664-56977BB8-20FB-4DE7-B431-28DE705E7B21Q27004073-103A16B2-C758-45C7-9DA6-37DA94F3126EQ27006914-E52A0536-6E13-4040-B24C-95CB0B4F8C24Q27333807-1405463C-822F-4DD1-AFD5-AC84D27A39A0Q28474937-E0A5EF6B-61F1-41F7-BE15-D98936CBFA8FQ28509726-89484D20-CD90-47A5-B8B5-90DF8FE91D4EQ28572534-6F38A0A2-9C3E-400A-8620-716798D8D371Q28729900-03F503D6-0FF3-4B5A-B42D-8E68C0144CCFQ30009415-DA4EC9D7-C68C-4112-B2D9-7A9986A9D800Q30009462-2558A546-329F-4709-82DD-4C2906CC1BF4Q30424169-EA0D058D-F8C0-44D2-AF0B-A30C353C4760Q30530966-2E802B60-4345-45B5-90BE-DAEBFEBC0F70Q33436829-EA019EFA-334F-4AE2-89CB-9FB684311FA6Q33597457-8EED2830-6A63-4AD9-8858-F7C52E4C20C8Q33634030-8271168D-E538-4D54-A4BC-2B317593BF81Q33653550-E90B3F7E-52F8-49F4-95BB-96D7D8F2D573Q33703811-0C7654FD-BC5B-403B-BFAA-8E9197C95604Q33744759-F9383120-E039-49AF-8082-8D0FAEB4AF75Q33792885-93EAAB71-7234-425D-858F-D7CC89211353Q33872286-F6EBDE84-71A6-4C75-A07E-0D8F486E7526Q33943247-2B0EE7BE-EA42-46E6-B40E-64984959F97BQ33943310-3CCCD5E8-9730-42AF-A104-BAEBC2871EA0Q33943315-16BEB18F-022E-4B82-BF1C-B4AABC6DA434Q33943376-7907F7D1-F1B0-4A90-8FD5-B289311F92D8Q34001289-DCB9707A-3775-4AF9-8963-BBE3F7C5021CQ34211578-6B2A64CF-37D2-440E-8C89-DC38D961DD9DQ34476390-C1FAC527-DA47-4A42-A04F-96F056BFD03BQ34760971-EB7F4A7A-9554-4B15-8A35-D02CA07ED645Q34974055-B688ABE6-688F-41F4-A37B-D95BA0BA7A3BQ35181072-EBEA2B1C-1B1A-490F-968A-0140554B6A9EQ35690375-1D7005C5-2A69-421F-8C06-278FDDA67E6DQ35916180-483E5D2E-EFED-4EDE-8857-10125603AD91Q35990846-E6D2A526-C4F0-4D77-9233-DD33AAA1FCEDQ36194753-D5885703-8181-4F32-BAC9-7E8CC488FF4FQ36195369-E78ECA8B-A567-4FD6-A8F5-E82FF9A260DFQ36217325-FD92FB51-292A-4E35-996D-7784595D7DB4Q36494428-4F6AA759-CB1A-4E2B-8507-B8DE23A1BD0D
P2860
Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Proteolytic processing of dyna ...... or proteinuric kidney disease.
@ast
Proteolytic processing of dyna ...... or proteinuric kidney disease.
@en
type
label
Proteolytic processing of dyna ...... or proteinuric kidney disease.
@ast
Proteolytic processing of dyna ...... or proteinuric kidney disease.
@en
prefLabel
Proteolytic processing of dyna ...... or proteinuric kidney disease.
@ast
Proteolytic processing of dyna ...... or proteinuric kidney disease.
@en
P2093
P2860
P356
P1476
Proteolytic processing of dyna ...... or proteinuric kidney disease.
@en
P2093
Ann Erickson
Boris Nikolic
Changli Wei
Clemens C Möller
Clemens D Cohen
Elizabetta C del Re
Jochen Reiser
Joel Henderson
Lianne Hsing
P2860
P304
P356
10.1172/JCI32022
P407
P577
2007-08-01T00:00:00Z